Virtus ETF Advisers’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-51,919
Closed -$266K 415
2021
Q3
$266K Sell
51,919
-4,755
-8% -$24.4K 0.12% 212
2021
Q2
$471K Buy
56,674
+8,726
+18% +$72.5K 0.19% 169
2021
Q1
$418K Buy
47,948
+1,310
+3% +$11.4K 0.18% 175
2020
Q4
$506K Buy
46,638
+12,952
+38% +$141K 0.21% 139
2020
Q3
$402K Buy
33,686
+2,837
+9% +$33.9K 0.21% 169
2020
Q2
$495K Buy
30,849
+10,543
+52% +$169K 0.23% 149
2020
Q1
$315K Sell
20,306
-2,966
-13% -$46K 0.13% 221
2019
Q4
$572K Buy
23,272
+1,552
+7% +$38.1K 0.09% 195
2019
Q3
$224K Sell
21,720
-1,210
-5% -$12.5K 0.05% 229
2019
Q2
$288K Sell
22,930
-22,532
-50% -$283K 0.06% 235
2019
Q1
$563K Sell
45,462
-5,376
-11% -$66.6K 1.2% 26
2018
Q4
$313K Buy
50,838
+20,983
+70% +$129K 0.05% 97
2018
Q3
$316K Sell
29,855
-21,348
-42% -$226K 0.03% 182
2018
Q2
$694K Sell
51,203
-8,127
-14% -$110K 0.61% 103
2018
Q1
$1.05M Buy
59,330
+31,789
+115% +$564K 0.91% 35
2017
Q4
$346K Buy
27,541
+832
+3% +$10.5K 0.43% 98
2017
Q3
$509K Buy
26,709
+2,443
+10% +$46.6K 0.07% 88
2017
Q2
$366K Sell
24,266
-1,062
-4% -$16K 0.05% 82
2017
Q1
$434K Buy
25,328
+2,428
+11% +$41.6K 0.08% 110
2016
Q4
$277K Buy
22,900
+1,150
+5% +$13.9K 0.08% 117
2016
Q3
$214K Hold
21,750
0.1% 135
2016
Q2
$223K Buy
21,750
+5,350
+33% +$54.9K 0.17% 120
2016
Q1
$199K Buy
+16,400
New +$199K 0.27% 83